LAB Earnings

Quarterly EPS
$-0.07
Q3 2024
$-0.09
Q4 2024
$-0.07
Q1 2025
$-0.09
Q2 2025
$-0.09
Q3 2025
$0.05
Q4 2025
$0.33
Q1 2026
$-0.07
Q2 2026
Latest Revenue20.1M
Latest Net Income-26758000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.0720.1M-26758000-7.6%+22.2%
Q1 2026$0.3321.1M127.1M+4.6%+571.4%
Q4 2025$0.0523.8M19.3M-4.0%+155.6%
Q3 2025-$0.0919.6M-34687000-11.5%-28.6%
Q2 2025-$0.0921.8M-33459000-3.2%+25.0%
Q1 2025-$0.0720.2M-26033000-55.6%+74.1%
Q4 2024-$0.0924.8M-34072000-12.1%+64.0%
Q3 2024-$0.0722.1M-26938000-12.9%+74.1%
Q2 2024-$0.1222.5M-45718000
Q1 2024-$0.2745.5M-32157000
Q4 2023-$0.2528.2M-19776000
Q3 2023-$0.2725.4M-20997000
Standard BioTools (LAB) — Earnings